H.R. 2038
Referred to CommitteeState-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019
Introduced 4/2/2019•116th Congress•House
Latest Action
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
5/15/2019 • House
Summary
State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019
This bill authorizes health insurance issuers to jointly negotiate the prices for prescription drugs with the manufacturers of such drugs.
Introduced in House • 4/2/2019
Enter your district to see how this bill affects your community
Topics & Subjects
Policy Area: Health
CancerChild healthChild safety and welfareCongressional oversightDrug, alcohol, tobacco useHealth care costs and insuranceHealth care coverage and accessHealth facilities and institutionsHealth personnelHealth programs administration and fundingLong-term, rehabilitative, and terminal carePrescription drugsRural conditions and developmentSales and excise taxesState and local finance
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (3)
Party Breakdown
0
Democrats
3
Republicans
0
Independents
Sponsor
R[
Cosponsors (2)
R[
R[
Bill Journey
Originated in the House
Introduced
April 2, 2019
Referred to the House Committee on the Judiciary.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law
Text Versions (1)
Introduced in House4/2/2019